Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Douglas N. Abrams"'
Autor:
Alexander J.B. McEwan, Joseph A. H. Romaniuk, Douglas N. Abrams, John S. Wilson, Jan Andersson, Katherine Gagnon, S.A. McQuarrie
Publikováno v:
Applied Radiation and Isotopes. 110:193-199
Hydrophobic adsorbents such as C18 and C30 were coated with PEG and subsequently used for the separation of Mo/Tc. The most effective resin for adsorbing PEG was the C18-U resin, which demonstrated a coating capacity of 97.6±2.8 mg PEG per g of resi
Autor:
Katherine Gagnon, S.A. McQuarrie, Alexander J.B. McEwan, John S. Wilson, Chris M. B. Holt, David Mitlin, Douglas N. Abrams
Publikováno v:
Applied Radiation and Isotopes. 70:1685-1690
There is growing interest in the large scale cyclotron production of 99m Tc via the 100 Mo(p,2n) 99m Tc reaction. While the use and recycling of cyclotron-irradiated enriched molybdenum targets has been reported previously in the context of 94m Tc pr
Publikováno v:
Current Radiopharmaceuticalse. 3:49-59
Technegas, a carbon-coated Tc-99m nanoparticulate aerosol invented by Burch at the Australian National University in 1984, was introduced to the medical community in 1986 with two reports of its use as a new ventilation agent for lung imaging. Since
Autor:
Piyush Kumar, Ernst J. Postema, Dacia A. Richmond, Leonard I. Wiebe, Douglas N. Abrams, Alexander J.B. McEwan, T. Riauka
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 36:1565-1573
Tumour hypoxia is thought to play a significant role in the outcome of solid tumour therapy. Positron emission tomography (PET) is the best-validated noninvasive technique able to demonstrate the presence of hypoxia in vivo. The locally developed PET
Publikováno v:
Synthetic Communications. 38:434-440
A new short and highly efficient synthesis of (5)‐2,3‐dimethoxy‐N[(1‐ethyl‐2‐pyrrolidinyl)methyl]‐5‐iodobenzamide (epidepride, 1) from 3‐methoxy‐salicylaldehyde (o‐vanillin, 2) and 3‐methoxysalicyclic acid (6) was achieved by
Publikováno v:
Nuclear Medicine Communications. 23:1091-1097
In accordance with the recommendations of the International Radiological Protection Commission, the current maximum acceptable radiation dose limits for members of the public have been reduced to 1 mSv in the United States, Canada, and European Union
Autor:
James R. Ballinger, Mervyn W. Billinghurst, Andrew M. Rauth, Zi-Fen Su,†,‡, Douglas N. Abrams
Publikováno v:
Bioconjugate Chemistry. 11:652-663
A novel amine-dioxime chelator for (99m)Tc has been developed. It offers the advantages of ease of synthesis and flexibility in alteration of lipophilicity. Labeling by stannous reduction of pertechnetate takes place rapidly and efficiently at room t
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 26:1458-1464
Huntington disease (HD) is characterized by severe abnormalities in neurotransmitter concentrations and neuroreceptor density. Quantitative changes in dopamine D(2) receptors occur in the early stages of HD and may be detectable with functional neuro
Autor:
S. A. McQuarrie, Katherine Gagnon, John S. Wilson, Douglas N. Abrams, Jan Andersson, Joseph A. H. Romaniuk
Publikováno v:
AIP Conference Proceedings.
After the production of 99mTc via the 100Mo(p,2n)99mTc reaction, there is a requirement for separating 99mTc from bulk 100Mo. Although a number of separation methods have been demonstrated, the possibility of using a cartridge-based system is particu
Publikováno v:
International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes. 43:1045-1049
Technetium-99m radiopharmaceuticals prepared for routine clinical use, were labelled with [99mTc]pertechnetate obtained from either a commercial chromatographic generator or from a Winnipeg Health Sciences Centre semi-automated self-shielded methyl e